文献速递妇科

妇科癌症患者衰弱与医疗资源使用及居家存活天数的关联:一项基于人群的研究

Association of frailty with healthcare utilization and days alive at home in patients with gynecologic cancers: a population-based study.
PubMed 文献 · Am J Obstet Gynecol · 2025-07-17

该研究利用全省行政数据,纳入2009至2021年间因妇科恶性肿瘤行剖腹术的21359例患者,采用术前衰弱指数和John Hopkins调整临床组衰弱指标定义衰弱。结果显示,衰弱与术后居家存活天数减少、家庭护理需求增加及医疗费用升高显著相关。

要点

  • 衰弱患者术后30天内及31至365天居家存活天数均显著少于非衰弱患者。
  • 衰弱患者术前一年内及术前任何时间需要家庭护理的比例显著更高。
  • 衰弱与术后31至365天总平均医疗费用增加显著相关。

核心结论

  • 衰弱与居家存活天数减少、家庭护理需求增加及医疗费用升高显著相关,凸显了针对该人群衰弱进行定制干预的迫切需求。

研究设计与样本

  • 基于全省行政数据的回顾性人群研究,纳入2009至2021年间因妇科恶性肿瘤行剖腹术的患者21359例。
  • 衰弱采用术前衰弱指数和John Hopkins调整临床组衰弱指标定义。

主要发现

  • 21359例患者中,术前衰弱指数定义衰弱1405例(6.6%),调整临床组定义衰弱1144例(5.4%)。
  • 术后30天内居家存活天数:术前衰弱指数衰弱组平均16.4天 vs 非衰弱组23.0天(P<.0001);调整临床组衰弱组17.7天 vs 非衰弱组22.8天(P<.0001)。
  • 术后31至365天居家存活天数:术前衰弱指数衰弱组234.5天 vs 非衰弱组308.2天(P<.0001);术前衰弱指数衰弱组248.0天 vs 非衰弱组306.5天(P<.0001),原文此处两组均写作术前衰弱指数,按上下文第二组应为调整临床组。
  • 多变量分析中,调整年龄、收入五分位、原发癌症、癌症分期、新辅助化疗、手术类型及合并症后,衰弱与术后31至365天居家存活天数显著相关(术前衰弱指数:率比0.86,95%CI 0.85-0.86,P<.0001;调整临床组:率比0.87,95%CI 0.86-0.87,P<.0001)。
  • 衰弱与家庭护理需求增加相关:术前一年内需要任何家庭护理的比例,术前衰弱指数衰弱组53.8% vs 非衰弱组9.6%(P<.0001),调整临床组衰弱组39.9% vs 非衰弱组10.9%(P<.0001);术前任何时间需要家庭护理的比例,术前衰弱指数衰弱组72.3% vs 非衰弱组19.4%(P<.0001),调整临床组衰弱组58.9% vs 非衰弱组20.8%(P<.0001)。

临床怎么用

  • 原文结论指出,衰弱与居家存活天数减少、家庭护理需求增加及医疗费用升高显著相关,凸显了针对该人群衰弱进行定制干预的迫切需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Existing research on frailty in Gynecologic Oncology is largely limited to short-term metrics and lacks comprehensive analysis of long-term patient-important outcomes and healthcare resource use. We sought to evaluate the association of frailty with days alive at home, healthcare costs, and other healthcare utilization indicators within 1 year after gynecologic oncology laparotomy. STUDY DESIGN: Using province-wide administrative data, we identified patients who underwent laparotomy for gynecologic malignancy between 2009 and 2021. Frailty was defined using the preoperative frailty index and the John Hopkins Adjusted Clinical Groups frailty indicator. RESULTS: Among the 21,359 patients, 1405 (6.6%) and 1144 (5.4%) were classified as frail using the preoperative frailty index and Adjusted Clinical Groups, respectively. Frail patients had fewer days alive at home both within the first 30 days postsurgery (preoperative frailty index: mean 16.4 vs 23.0 days, P<.0001; Adjusted Clinical Groups: 17.7 vs 22.8 days, P<.0001) and from 31 to 365 days postsurgery (preoperative frailty index: 234.5 vs 308.2 days, P<.0001; preoperative frailty index: 248.0 vs 306.5 days, P<.0001), than those who were not frail. In multivariate analysis, frailty was significantly associated with days alive at home within 31 to 365 days of surgery (preoperative frailty index: rate ratio, 0.86; 95% confidence interval [CI], 0.85-0.86; P<.0001, Adjusted Clinical Groups: rate ratio,0.87; 95% CI, 0.86-0.87; P<.0001) when adjusting for age, income quintile, primary cancer, cancer stage, neoadjuvant chemotherapy, type of surgery, and comorbidities. Frailty was also associated with increased need for home care, with frail patients more likely to have required any home care in the year prior to surgery (preoperative frailty index: 53.8% vs 9.6%, P<.0001; Adjusted Clinical Groups: 39.9% vs 10.9%, P<.0001) and at any time prior to surgery (preoperative frailty index: 72.3% vs 19.4%, P<.0001; Adjusted Clinical Groups: 58.9% vs 20.8%, P<.0001). Both frailty indexes were associated with an increase in total mean healthcare costs between 31 to 365 days after surgery (preoperative frailty index: $26,351 vs $9,853, P<.0001, Adjusted Clinical Groups: $23,922 vs $10,203, P<.0001). This remained significant on multivariate analysis (preoperative frailty index: cost rate ratio, 1.65; 95% CI, 1.53-1.77; P<.0001, Adjusted Clinical Groups: cost rate ratio, 1.83; 95% CI, 1.7-1.97; P<.0001). CONCLUSION: Frailty was significantly associated with fewer days alive at home, increased need for home care, as well as higher healthcare costs. This highlights the critical need for tailored interventions to address frailty in this population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Nguyen JMV, Zigras T, Gayowsky A, et al. Association of frailty with healthcare utilization and days alive at home in patients with gynecologic cancers: a population-based study. Am J Obstet Gynecol. 2025. PMID: 40683585. doi:10.1016/j.ajog.2025.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。